As of 2026-04-07, the EV/EBITDA ratio of Exagen Inc (XGN) is -5.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 67.86 mil USD. XGN's TTM EBITDA according to its financial statements is -13.46 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 7.7x | 7.4x |
| Forward P/E multiples | 6.1x - 9.8x | 8.1x |
| Fair Price | (3.75) - (4.03) | (4.11) |
| Upside | -221.7% - -230.8% | -233.3% |
| Date | EV/EBITDA |
| 2026-04-06 | -5.04 |
| 2026-04-02 | -5.01 |
| 2026-04-01 | -4.92 |
| 2026-03-31 | -4.90 |
| 2026-03-30 | -4.27 |
| 2026-03-27 | -4.33 |
| 2026-03-26 | -4.52 |
| 2026-03-25 | -4.68 |
| 2026-03-24 | -4.43 |
| 2026-03-23 | -4.63 |
| 2026-03-20 | -4.51 |
| 2026-03-19 | -4.85 |
| 2026-03-18 | -4.93 |
| 2026-03-17 | -5.20 |
| 2026-03-16 | -5.19 |
| 2026-03-13 | -5.02 |
| 2026-03-12 | -5.19 |
| 2026-03-11 | -5.10 |
| 2026-03-10 | -5.35 |
| 2026-03-09 | -5.58 |
| 2026-03-06 | -5.42 |
| 2026-03-05 | -5.29 |
| 2026-03-04 | -5.95 |
| 2026-03-03 | -5.67 |
| 2026-03-02 | -5.88 |
| 2026-02-27 | -6.01 |
| 2026-02-26 | -6.33 |
| 2026-02-25 | -6.33 |
| 2026-02-24 | -6.13 |
| 2026-02-23 | -6.15 |
| 2026-02-20 | -5.63 |
| 2026-02-19 | -5.38 |
| 2026-02-18 | -5.40 |
| 2026-02-17 | -5.45 |
| 2026-02-13 | -5.40 |
| 2026-02-12 | -5.33 |
| 2026-02-11 | -5.44 |
| 2026-02-10 | -5.79 |
| 2026-02-09 | -5.56 |
| 2026-02-06 | -5.81 |
| 2026-02-05 | -5.54 |
| 2026-02-04 | -5.81 |
| 2026-02-03 | -6.17 |
| 2026-02-02 | -6.38 |
| 2026-01-30 | -6.11 |
| 2026-01-29 | -6.60 |
| 2026-01-28 | -6.79 |
| 2026-01-27 | -7.24 |
| 2026-01-26 | -7.42 |
| 2026-01-23 | -7.76 |